<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">fcmedicine</journal-id><journal-title-group><journal-title xml:lang="ru">Фундаментальная и клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Fundamental and Clinical Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2500-0764</issn><issn pub-type="epub">2542-0941</issn><publisher><publisher-name>КемГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23946/2500-0764-2021-6-4-98-105</article-id><article-id custom-type="elpub" pub-id-type="custom">fcmedicine-471</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Изучение заболеваемости и частоты возможных факторов риска рассеянного склероза</article-title><trans-title-group xml:lang="en"><trans-title>Incidence of multiple sclerosis and prevalence of its risk factors in Russian Federation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9189-506X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Светличная</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Svetlichnaya</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Светличная Анастасия Владимировна, аспирант кафедры эпидемиологии и доказательной медицины Института общественного здоровья им Ф. Ф. Эрисмана</p><p>119991, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Anastasia V. Svetlichnaya, Dr. MD, PhD Student, Department of Epidemiology and Evidence-Based Medicine, Erisman Institute of Public Health</p><p>8/2, Trubetskaya Street, Moscow, 119991</p></bio><email xlink:type="simple">anastasia.svetlichnaya2015@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3986-9566</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вязовиченко</surname><given-names>Ю. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Vyazovichenko</surname><given-names>Yu. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вязовиченко Юрий Евгеньевич, доктор медицинских наук, профессор, профессор кафедры эпидемиологии и доказательной медицины Института общественного здоровья им. Ф. Ф. Эрисмана</p><p>119991, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Yuri E. Vyazovichenko, Prof. MD, DSc, Professor, Department of Epidemiology and Evidence-Based Medicine, Erisman Institute of Public Health</p><p>8/2, Trubetskaya Street, Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3835-0842</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торчинский</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Torchinskiy</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торчинский Николай Викторович, кандидат медицинских наук, доцент, доцент кафедры эпидемиологии и доказательной медицины Института общественного здоровья им. Ф. Ф. Эрисмана</p><p>119991, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Nikolay V. Torchinskiy, Dr. MD, PhD, Associate Professor, Department of Epidemiology and Evidence-Based Medicine, Erisman Institute of Public Health</p><p>8/2, Trubetskaya Street, Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2562-9695</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коршунов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Korshunov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коршунов Владимир Андреевич, кандидат медицинских наук, доцент кафедры эпидемиологии и доказательной медицины Института общественного здоровья им. Ф. Ф. Эрисмана</p><p>119991, г. Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Vladimir A. Korshunov, Dr. MD, PhD, Associate Professor, Department of Epidemiology and Evidence-Based Medicine, Erisman Institute of Public Health</p><p>8/2, Trubetskaya Street, Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет) Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2021</year></pub-date><volume>6</volume><issue>4</issue><fpage>98</fpage><lpage>105</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Светличная А.В., Вязовиченко Ю.Е., Торчинский Н.В., Коршунов В.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Светличная А.В., Вязовиченко Ю.Е., Торчинский Н.В., Коршунов В.А.</copyright-holder><copyright-holder xml:lang="en">Svetlichnaya A.V., Vyazovichenko Y.E., Torchinskiy N.I., Korshunov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://fcm.kemsmu.ru/jour/article/view/471">https://fcm.kemsmu.ru/jour/article/view/471</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить заболеваемость рассеянным склерозом населения Российской Федерации и выявить наиболее часто встречающиеся факторы риска.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследовании были использованы официальные статистические данные Министерства здравоохранения Российской Федерации и проведено анкетирование среди пациентов клиники нервных болезней им. А.Я. Кожевникова Сеченовского Университета с диагнозом «рассеянный склероз» в количестве 50 человек (16 мужчин и 34 женщины).</p></sec><sec><title>Результаты</title><p>Результаты. Среднемноголетний показатель заболеваемости РС совокупного населения составляет 3,8 на 100 тыс. населения. Установлен выраженный рост заболеваемости населения Российской Федерации рассеянным склерозом с 2009-го по 2019 год. В структуре заболеваемости наиболее высокие показатели выявлены в Центральном федеральном округе (4,5 на 100 тыс.), самые низкие − в Дальневосточном федеральном округе (2 на 100 тыс.). Выявлены наиболее часто встречающиеся факторы риска среди пациентов, такие как женский пол, перенесенные вирусные заболевания, наличие очагов хронической бактериальной инфекции и эмоциональный стресс.</p></sec><sec><title>Заключение</title><p>Заключение. Выявлена тенденция к росту заболеваемости РС в Российской Федерации с выраженной территориальной неравномерностью. Показана необходимость изучения влияния инфекционной патологии и эмоционального стресса на риск развития РС, уточнения роли других факторов риска в современных условиях.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the incidence and prevalence of multiple sclerosis risk factors in Russian Federation from 2009 to 2019.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. We used official records of Ministry of Health of Russian Federation and conducted a survey of 50 patients with multiple sclerosis (16 men and 34 women) admitted to the Sechenov University Clinic of Neurological Disorders to determine subjective risk factors.</p></sec><sec><title>Results</title><p>Results. Current incidence of multiple sclerosis in Russian Federation is 3.8 per 100,000 population, with a steady increase from 2009 to 2019. The highest and the lowest incidence values were registered in the Central Federal District (4.5 per 100,000 population) and Far Eastern Federal District (2.0 per 100,000 population). The most common subjective risk factors were female gender, past medical history of viral diseases, chronic bacterial infections, and emotional stress.</p></sec><sec><title>Conclusion</title><p>Conclusion. Incidence of multiple sclerosis in Russian Federation is currently rising that highlights the need in the improved therapeutic protocols.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>эпидемиология</kwd><kwd>рассеянный склероз</kwd><kwd>аутоиммунные заболевания</kwd><kwd>вирусные заболевания</kwd><kwd>факторы риска</kwd><kwd>анкетирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>epidemiology</kwd><kwd>multiple sclerosis</kwd><kwd>autoimmune diseases</kwd><kwd>viral diseases</kwd><kwd>risk factors</kwd><kwd>questionnaires</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы выражают признательность сотрудникам клиники нервных болезней им. А.Я. Кожевникова и лично к.м.н., доценту Шмидт Татьяне Евгеньевне за оказанную помощь при проведении анкетирования.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S. Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2018;20:43-47. https://doi.org/10.1016/j.msard.2017.12.015</mixed-citation><mixed-citation xml:lang="en">Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S. Worldwide preva-lence of familial multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2018;20:43-47. https://doi.org/10.1016/j.msard.2017.12.015</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Захарова М.Ю., Белянина Т.А., Соколов А.В., Киселев И.С., Мамедов А.Э. Вклад генов главного комплекса гистосовместимости класса II в предрасположенность к аутоиммунным заболеваниям. Acta Naturae. 2019;11(4 (43):4-12. https://doi.org/10.32607/20758251-2019-11-4-4-12</mixed-citation><mixed-citation xml:lang="en">Zakharova MYu, Belyanina TA, Sokolov AV, Kiselev IS, Mamedov AE. The contribution of major histocompatibility complex class II genes to an association with autoimmune diseases. ActaNaturae. 2019;11(4 (43):4-12. (in Russ). https://doi.org/10.32607/20758251-2019-11-4-4-12</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14): 1816-1821. https://doi.org/10.1177/1352458520970841</mixed-citation><mixed-citation xml:lang="en">Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816-1821. https://doi.org/10.1177/1352458520970841</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Golden LC, Voskuhl R. The importance of studying sex differences in disease: The example of multiple sclerosis. J Neurosci Res. 2017;95(1-2):633-643. https://doi.org/doi:10.1002/jnr.23955</mixed-citation><mixed-citation xml:lang="en">Golden LC, Voskuhl R. The importance of studying sex differences in disease: The example of multiple sclerosis. J Neurosci Res. 2017;95(1-2):633-643. https://doi.org/doi:10.1002/jnr.23955</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y. Sex-based differences in autoimmune diseases. Ann Ist Super Sanita. 2016;52(2):205-212. https://doi.org/10.4415/ANN_16_02_12</mixed-citation><mixed-citation xml:lang="en">Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y. Sex-based differences in autoimmune diseases. Ann Ist Super Sanita. 2016;52(2):205-212. https://doi.org/10.4415/ANN_16_02_12</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tincani A, Nalli C, Khizroeva J, Bitsadze V, Lojacono A, Andreoli L, Shoenfeld Y, Makatsariya A. Autoimmune diseases and pregnancy. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101322. https://doi.org/10.1016/j.beem.2019.101322</mixed-citation><mixed-citation xml:lang="en">Tincani A, Nalli C, Khizroeva J, Bitsadze V, Lojacono A, Andreoli L, Shoenfeld Y, Makatsariya A. Autoimmune diseases and pregnancy. Best Pract Res Clin Endo-crinol Metab. 2019;33(6):101322. https://doi.org/10.1016/j.beem.2019.101322</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wu GF. X-tra X: An escape to autoimmunity. J Clin Invest. 2019;129(9):3536-3538. https://doi.org/10.1172/JCI130312</mixed-citation><mixed-citation xml:lang="en">Wu GF. X-tra X: An escape to autoimmunity. J Clin Invest. 2019;129(9):3536-3538. https://doi.org/10.1172/JCI130312</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2021;11:587380. https://doi.org/10.3389/fimmu.2020.587380</mixed-citation><mixed-citation xml:lang="en">Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2021;11:587380. https://doi.org/10.3389/fimmu.2020.587380</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Auer M, Borena W, Holm-von Laer D, Deisenhammer F. Correlation between anti-JC-virus and anti-cytomegalovirus, -Epstein-Barr virus and -measles/-rubella/-varicella-zoster-virus antibodies. J Med Virol. 2017;89(1):3-9. https://doi.org/10.1002/jmv.24590</mixed-citation><mixed-citation xml:lang="en">Auer M, Borena W, Holm-von Laer D, Deisenhammer F. Correlation between an-ti-JC-virus and anti-cytomegalovirus, -Epstein-Barr virus and -measles/-rubella/-varicella-zoster-virus antibodies. J Med Virol. 2017;89(1):3-9. https://doi.org/10.1002/jmv.24590</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rubin K, Glazer S. The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis. Immunobiology. 2016;221(4):512-5. https://doi.org/10.1016/j.imbio.2015.12.008</mixed-citation><mixed-citation xml:lang="en">Rubin K, Glazer S. The potential role of subclinical Bordetella Pertussis coloniza-tion in the etiology of multiple sclerosis. Immunobiology. 2016;221(4):512-5. https://doi.org/10.1016/j.imbio.2015.12.008</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dolei A. The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis. Mult Scler. 2018;24(1):42-47. https://doi.org/10.1177/1352458517737370</mixed-citation><mixed-citation xml:lang="en">Dolei A. The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis. Mult Scler. 2018;24(1):42-47. https://doi.org/10.1177/1352458517737370</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Christensen T. Human endogenous retroviruses in the aetiology of MS. Acta Neurol Scand. 2017;136 Suppl 201:18-21. https://doi.org/10.1111/ane.12836</mixed-citation><mixed-citation xml:lang="en">Christensen T. Human endogenous retroviruses in the aetiology of MS. Acta Neu-rol Scand. 2017;136 Suppl 201:18-21. https://doi.org/10.1111/ane.12836</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Manouchehrinia A, Tanasescu R, Kareem H, Jerca OP, Jabeen F, Shafei R, Breuer J, Neal K, Irving W, Constantinescu CS. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis. J Neurovirol. 2017;23(6):839-844. https://doi.org/10.1007/s13365-017-0569-1</mixed-citation><mixed-citation xml:lang="en">Manouchehrinia A, Tanasescu R, Kareem H, Jerca OP, Jabeen F, Shafei R, Breuer J, Neal K, Irving W, Constantinescu CS. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis. J Neurovirol. 2017;23(6):839-844. https://doi.org/10.1007/s13365-017-0569-1</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, Kümpfel T, Hohlfeld R, Krishnamoorthy G, Wekerle H. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA. 2017;114(40):10719-10724. https://doi.org/10.1073/pnas.1711233114</mixed-citation><mixed-citation xml:lang="en">Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauf-fer U, Baranzini SE, Kümpfel T, Hohlfeld R, Krishnamoorthy G, Wekerle H. Gut mi-crobiota from multiple sclerosis patients enables spontaneous autoimmune encephalo-myelitis in mice. Proc Natl Acad Sci USA. 2017;114(40):10719-10724. https://doi.org/10.1073/pnas.1711233114</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Abdollahpour I, Nedjat S, Mansournia MA, Eckert S, Weinstock-Guttman B. Stress-full life events and multiple sclerosis: A population-based incident case-control study. Mult Scler Relat Disord. 2018;26:168-172. https://doi.org/10.1016/j.msard.2018.09.026</mixed-citation><mixed-citation xml:lang="en">Abdollahpour I, Nedjat S, Mansournia MA, Eckert S, Weinstock- Guttman B. Stress-full life events and multiple sclerosis: A population-based incident case-control study. Mult Scler Relat Disord. 2018;26:168-172. https://doi.org/10.1016/j.msard.2018.09.026</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">AlZahrani AS, Alshamrani FJ, Al-Khamis FA, Al-Sulaiman AA, Al Ghamdi WS, Al Ghamdi OA, Mohammad MY, Alshayea MS, Alhazmi RA, Alkhaja MA. Association of acute stress with multiple sclerosis onset and relapse in Saudi Arabia. Saudi Med J. 2019;40(4):372-378. https://doi.org/10.15537/smj.2019.4.24010</mixed-citation><mixed-citation xml:lang="en">AlZahrani AS, Alshamrani FJ, Al-Khamis FA, Al-Sulaiman AA, Al Ghamdi WS, Al Ghamdi OA, Mohammad MY, Alshayea MS, Alhazmi RA, Alkhaja MA. Association of acute stress with multiple sclerosis onset and relapse in Saudi Arabia. Saudi Med J. 2019;40(4):372-378. https://doi.org/10.15537/smj.2019.4.24010</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Xie Y, Tian Z, Han F, Liang S, Gao Y, Wu D. Factors associated with relapses in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99(27):e20885. https://doi.org/10.1097/MD.0000000000020885</mixed-citation><mixed-citation xml:lang="en">Xie Y, Tian Z, Han F, Liang S, Gao Y, Wu D. Factors associated with relapses in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99(27):e20885. https://doi.org/10.1097/MD.0000000000020885</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wicks CR, Sloan R, DiMauro S, Thompson EL, Billington S, Webb M, Pepper G. Patients' experiences of self-identification, seeking support, and anticipation of potential relapse in multiple sclerosis. Mult Scler Relat Disord. 2021;56:103259. https://doi.org/10.1016/j.msard.2021.103259</mixed-citation><mixed-citation xml:lang="en">Wicks CR, Sloan R, DiMauro S, Thompson EL, Billington S, Webb M, Pepper G. Patients' experiences of self-identification, seeking support, and anticipation of potential relapse in multiple sclerosis. Mult Scler Relat Disord. 2021;56:103259. https://doi.org/10.1016/j.msard.2021.103259</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jasper EA, Nidey NL, Schweizer ML, Ryckman KK. Gestational vitamin D and offspring risk of multiple sclerosis: a systematic review and meta-analysis. Ann Epidemiol. 2020;43:11-17. https://doi.org/10.1016/j.annepidem.2019.12.010</mixed-citation><mixed-citation xml:lang="en">Jasper EA, Nidey NL, Schweizer ML, Ryckman KK. Gestational vitamin D and offspring risk of multiple sclerosis: a systematic review and meta-analysis. Ann Epi-demiol. 2020;43:11-17. https://doi.org/10.1016/j.annepidem.2019.12.010</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Arneth B. Multiple Sclerosis and Smoking. Am J Med. 2020;133(7):783-788. https://doi.org/10.1016/j.amjmed.2020.03.008</mixed-citation><mixed-citation xml:lang="en">Arneth B. Multiple Sclerosis and Smoking. Am J Med. 2020;133(7):783-788. https://doi.org/10.1016/j.amjmed.2020.03.008</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
